Our Feature Articles are stories that cover a personal side of a company or highlight a company’s products or services and how they fit into the industry they call home. Unlike straight news stories… these articles are a great way to get closer to the company and learn a side of the company that isn’t strictly related to a news event.
To read any of our Feature Articles on this page, click the link below the picture, or just click on the picture above the Headline. If you would like us to do a Feature Article on your company, release it through the media and house it on our site, please contact us to schedule a meeting.
NVLX Content Page IOGA Content Page PLPL Content Page
Feature News Story: Plandai Biotechnology, Inc. ι Product Proven to Decrease Healing Time of Sports Related Injuries
Feature News Story: Nuvilex, Inc. & Celgene Corp. ι Can Both Replace Eli Lilly’s Cancer Drug, Gemzar
Feature News Story: Nuvilex, Inc. ι Cell Encapsulation Could Mimic Combination Chemotherapy
Feature News Story: Plandai Biotechnology, Inc. ι New Products to Hit the Market with Higher Absorption Rate
Feature News Story: INSCOR, Inc. ι Investors Begin to Realize Huge Potential Market for Company’s Products
Feature News Story: Nuvilex, Inc. ι COO Discusses Phase III Pancreatic Cancer Trials, Study Sites, Fast Track, Orphan Drug Status and More
Feature News Story: Plandai Biotechnology, Inc. ι Molecularly Changing the Botanical Extract Industry
Feature News Story: Nuvilex, Inc. ι Shows Success Treating Mammary Tumors Using Cell Encapsulation Technology
Feature News Story: Nuvilex, Inc. ι Pancreatic Cancer Therapy Offers Higher Survival Rate & Less Toxicity Than Competitors
Feature News Story: Nuvilex, Inc. ι Pancreatic Cancer Trials Could Make “Cell-in-a-Box” Gold Standard
Feature News Story: Nuvilex, Inc. ι Price Valuation Justifies Investor Confidence in Biotech
Feature News Story: Nuvilex, Inc. & Diabetes Research Institute Have Similar Approach to Islet Cell Transplantation
Feature News Story: Human Clinical Trials Using Medical Marijuana Could Be Close in the U.S.
Feature News Story: Nuvilex, Inc. ι Can Benefit from Passage of This Week’s Medical Marijuana Bill
Feature News Story: Nuvilex, Inc. ι Expects its Technology Can Start to Change Life for Diabetics
Feature News Story: LifeApps Digital Media, Inc. ι is on the Right Side of Growing Trend
Feature News Story: INSCOR, Inc. ι A Penny Stocks Funding Solution to America’s Trillion Dollar Problem
Feature News Story: Nuvilex, Inc. ι Phase III Clinical Trials in Strong Hands with Dr. Gerald Crabtree
Feature News Story: Potential Future Sales of Nuvilex, Inc. Cancer Treatments Make Investment in Cell-in-a-Box Worth It
Feature News Story: Timing is Right for Big Pharma to Add Nuvilex, Inc. Technology to its Pipeline
Feature News Story: Nuvilex, Inc. ι Diabetes Studies Could Eliminate Need for Daily Insulin Requirements
Feature News Story: Nuvilex, Inc. ι Another Biotech Changing the Face of Medical Marijuana
Feature News Story: Nuvilex, Inc. ι Cell-in-a-Box Technology Could Revitalize Stem Cell Phenomenon
Feature News Story: Celgene, Corp., Nuvilex, Inc. ι on Similar Path in Fight Against Pancreatic Cancer
Feature News Story: Nuvilex, Inc. ι Finding the Green is in the Science
Feature News Story: Action Products ι Taps American Hero as Chairman
Feature News Story: Baristas Coffee Company ι Not Just Selling A Cup O’ Joe
The stem cell industry lost one of its key players earlier this month when industry pioneer, Geron Corporation announced its intention to exit the stem cell research market.
It’s that time again. Black Friday has arrived again, and with it the crowds of shoppers, the big promotions, and the analysts who fret that the next several weeks will make or break the year for retailers.
The South Korean Parliament just approved a free trade agreement with the United States. According to an article in The Wall Street Journal, agricultural exports from the US to South Korea will rise.
If you plan on trading penny stocks, it would be a good idea to have a good understanding of how the middle tier of the over-the-counter (OTC) market works – the OTCQB market.
Recent News Posts
GDTK ι GDT Tek, Inc. Our Tuesday Low Float Alert with News
After yesterday’s Close, we emailed Subscribers our latest low float Alert… it’s a company that is really making …
Read More
Plandai Biotechnology, Inc. Product Proven to Decrease Healing Time of Sports Related Injuries
Written by ι Stock House Group Staff — May 21, 2013
In a series of articles to introduce Plandaí Biotechno…
Read More
Nuvilex, Inc. and Celgene Corp. Can Both Replace Eli Lilly’s Cancer Drug Gemzar
Written by ι Stock House Group Staff — May 20, 2013
The race is on, and patients with advanced stage, inope…
Read More
ForeverGreen Worldwide Corp. Research Report Launched
We have launched our Latest Research Report — ForeverGreen Worldwide, Corp. (OTCQB: FVRG), a nutraceutical comp…
Read More